Skip to main content
OpenTrials

Clinical trial condition

Sarcoma, Ewing

Explore clinical trials studying Sarcoma, Ewing. Study availability and eligibility vary by location and protocol.

192 public trials 53 recruiting studies
Refine in advanced search Browse all conditions

Sarcoma, Ewing trial results

Completed

A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma

NCT02511132

Conditions
Ewing's Sarcoma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Nicklaus Children's Hospital (Miami Children's Health System) Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Cleveland Clinic Children's Cleveland, Ohio, United States
View Trial Details
Completed

Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)

NCT03441360

Conditions
Ewing Sarcoma, Myosarcoma, Neoplasms, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 41 locations
View Trial Details
Completed

Protocol for the Treatment of Metastatic Ewing Sarcoma

NCT02727387

Conditions
Ewing's Sarcoma (ES), Neoplasms, Neoplasms by Histologic Type, +6 more
Locations
  • Centro di Riferimento Oncologico - Unit of Medical Oncology Aviano, Pordenone, Italy
  • I.R.C.C. - Unit of Medical Oncology Candiolo, Torino, Italy
  • Azienda ospedaliero universitaria consorziale policlinico - bari Bari, Italy
  • Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Bologna, Italy
View all 13 locations
View Trial Details
Completed

Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma

NCT02063022

Conditions
Ewing's Sarcoma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations
  • Centro di Riferimento Oncologico - Unit of Medical Oncology Aviano, Pordenone, Italy
  • I.R.C.C. - Unit of Medical Oncology Candiolo, Torino, Italy
  • IRCCS materno infantile Burlo Garofolo Trieste, T, Italy
  • Azienda Ospedaliero Universitaria Consorziale Policlinico - Bari Bari, Italy
View all 14 locations
View Trial Details
Completed

Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors

NCT03245450

Conditions
Ewing Sarcoma, Myosarcoma, Neoplasms, +11 more
Locations
  • Hopitaux de La Timone Marseille, Bouches-du-Rhône, France
  • Centre Oscar Lambret Lille, Nord, France
  • Centre Léon Berard Lyon, Rhône, France
  • Eisai Trial Site 4 Freiburg im Breisgau, Baden-Wurttemberg, Germany
View all 39 locations
View Trial Details
Completed

Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma

NCT03275818

Conditions
Desmoid, Desmoid Tumors, Desmoplastic Small Round Cell Tumor, +16 more
Locations
  • H. de la Santa Creu i Sant Pau Barcelona, Spain
  • H. Sant Joan de Déu Barcelona, Spain
  • H.U. 12 de Octubre Madrid, Spain
  • H.U.Niño Jesús Madrid, Spain
View Trial Details
Completed

Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer

NCT01061840

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +21 more
Locations
  • Florida Cancer Specialists West Palm Beach, Florida, United States
  • Dartmouth-Hitchcock Medical Center/ Norris Cotton Cancer Center Lebanon, New Hampshire, United States
  • Mary Crowley Cancer Research Centers Dallas, Texas, United States
  • Cancer Care Northwest Spokane, Washington, United States
View Trial Details
Completed

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

NCT02982941

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Ewing Sarcoma, +33 more
Locations
  • Lucile Packard Children's Hospital, Stanford Palo Alto, California, United States
  • National Cancer Institute, Center for Cancer Research Bethesda, Maryland, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details

Related conditions